All News

May 26, 2022

As imaging volume continues to escalate for radiologists, more and more health-care facilities are turning to mobile imaging for increased efficiencies and benefits for patient care.

May 26, 2022

Deep radiomics models that included deep learning features had a 40 percent or greater increase in the specificity rate for diagnosing osteoporosis on hip radiographs in comparison to models that only emphasized clinical and/or textural features.

May 25, 2022

The new artificial intelligence-powered software reportedly helps detect central pulmonary embolism (PE) on computed tomography pulmonary angiogram (CTPA) images and streamlines communication among interventional teams to bolster treatment outcomes.

May 25, 2022

In a study of over 11,500 patients who had BI-RADS 4 breast lesions with no prior history of breast cancer, researchers found no statistically significant differences between digital mammography and digital breast tomosynthesis in cancer detection rates or biopsy-derived positive predictive value.

May 24, 2022

A new study revealed that an emerging artificial intelligence (AI)-enabled software tool led to improved sensitivity, specificity and inter-observer agreement for the diagnosis of indeterminate pulmonary nodules on chest computed tomography (CT) scans.

May 23, 2022

A closer look at the literature suggests the combination of digital breast tomosynthesis (DBT) and two-dimensional (2D) digital mammography (DM) has relatively equivalent cancer detection rates as using DM alone, according to a recent presentation at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) conference.

May 23, 2022

Amid a glut of unnecessary imaging requests, common worklist frustrations and perceptions from other clinicians that they can interpret medical images just as well, recognizing your role as a humble difference maker may provide the ultimate RVU for patients.

May 21, 2022

Catch up on the top radiology content of the past week.

May 20, 2022

While COVID-19 vaccine clinical trials noted that post-vaccine axillary lymphadenopathy lasted for one to 10 days, emerging breast ultrasound research found a mean resolution of 127 days after a first vaccine dose.

May 18, 2022

In a recent video interview, two radiology professors from the Yale School of Medicine discussed the impact of the iodinated contrast media (ICM) shortage and potential strategies, ranging from ICM dose reduction to possible deferment of non-urgent imaging, that may provide a viable path moving forward.